The prevalence of overweight and obesity is reaching epidemic proportions in Western countries, and is the second leading
cause of preventable death following tobacco use. Obesity is defined as a body mass index (BMI) of ≥30 kg/m2 or greater,
morbid obesity as a BMI ≥35 kg/m2, and super-morbid obesity as a BMI ≥50 kg/m2. Obese individua ls have a higher preva‐
lence of CV risk factors and a higher risk of death, and are a population who are at increased risk of adverse events in the
case of surgical procedures.
On the one side, there exist specific recommendations for the pre-operative risk assessment of obese patients undergoing
NCS, regardless of the presence of pre-existing cardiac conditions. On the other side, while obesity accelerates the propen‐
sity for CVD, it seems that many types of CVD may have a better prognosis in the overweight population compared with their
leaner counterparts, a phenomenon that is known as the ‘obesity paradox'.
Recommendations for management of patients with obesity undergoing non-cardiac surgery
Recommendations Classa Levela
It is recommended to assess cardiorespiratory fitness to estimate pe‐
rioperative CV risk in the obese patient, with particular attention to I B
those undergoing intermediate and high-risk NCS.
In patients at high risk of obesity hypoventilation syndrome, addition‐
al specialist investigation before major elective NCS should be con‐ IIa C
sidered.
CV, cardiovascular; NCS, non-cardiac surgery.
a
Class of recommendation and level of evidence as defined in Tables 1 and 2.